PVC Response ''Atrial Pace'' Inducing Atrial Tachycardias
Switching PVC Response ''Atrial Pace'' in ST JUDE Medical or Abbott ICD (Implantable Cardioverter Defibrillator) or CRT-D (Cardiac Resynchronization Therapy) Devices to Off Mode Decreases the Burden of Atrial Tachycardia
1 other identifier
interventional
16
1 country
1
Brief Summary
Premature ventricular contractions (PVC) are common phenomenon and occasionally retrograde conduction from ventricle to atrium occurs and may cause pacemaker mediated tachycardia. In response certain Abbott (former St Jude Medical) pacemakers have a specific PVC response algorithm ''Atrial Pace''. In this algorithm the PVARP (Post Ventricular Atrial Refractory Period) is extended to 480ms but the initial 150ms of the PVARP is deemed absolute. If atrial sensed event occurs after absolute PVARP the PVARP terminates and atrial pace follows after 330ms alert period. Two case reports exists where patients atrial tachycardia were suspected to be induced by this algorithm. In Helsinki University Hospital an index patient with multiple atrial tachycardia episodes was recognized in late 2020 where the cause of the tachycardias was suspected to be the PVC response algorithm ''Atrial Pace''. After programming the algorithm from Atrial Pace to off mode the patient had none atrial tachycardias during 2021. After investigating all the patients with physiological ICD (Implantable Cardioverter Defibrillator) or CRT-D (Cardiac Resynchronization Therapy) device and analyzing remote monitoring transmissions from the year 2020 we found 25 patients with similar atrial tachycardia episodes possibly induced by the PVC response ''Atrial Pace''.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2022
CompletedFirst Posted
Study publicly available on registry
April 25, 2022
CompletedStudy Start
First participant enrolled
May 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2023
CompletedFebruary 28, 2024
February 1, 2024
21 days
April 14, 2022
February 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of atrial tachycardia episodes per participant which is initiated after PVC followed by atrial sensed event and atrial pace after 330ms delay.
Atrial tachycardia episode is considered as an episode which duration is \>30s and atrial rate \> 180 beats per minute.
The number of these episodes is compared between year 2020 and 12 months preceding the change in the programming setting and 12 months afterwards.
Number of any atrial tachycardia episodes and overall duration of atrial tachycardia episodes per participant.
Atrial tachycardia episode is considered as an episode which duration is \>30s and atrial rate \> 180 beats per minute.
The number of these episodes and overall duration of all atrial tachycardia episodes is compared between year 2020 and 12 months preceding the change in the programming setting and 12 months afterwards.
Secondary Outcomes (1)
Composite Change in the quality of life analyzed with EQ-5D-3L and ICD8 questionaries'.
baseline and after 12 months surveillance
Study Arms (1)
PVC response ''Off''
EXPERIMENTALInterventions
PVC algorithm change from Atrial Pace mode to Off
Eligibility Criteria
You may qualify if:
- ST Jude Medical or Abbott physiological ICD or CRT-D device
- PVC response setting ''Atrial Pace''
- Atrial tachycardia episode duration \> 30s preceded by ventricular extrasystole and atrial pace in year 2020 or 2021
You may not qualify if:
- Permanent atrial fibrillation, duration ≥ 6 months before the enrollment to the study
- PVC response has been switched off before enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helsinki University Central Hospital
Helsinki, Finland
Related Publications (2)
Friedman DJ, Chasten T, Anderson K, Mullenix J, Rider K, Sun AY. Premature ventricular contraction response-induced new-onset atrial fibrillation. HeartRhythm Case Rep. 2018 Nov 30;5(3):120-123. doi: 10.1016/j.hrcr.2018.11.012. eCollection 2019 Mar. No abstract available.
PMID: 30891406BACKGROUNDLiu Y, Yuan X. Logic Analysis of Arrhythmia Triggered by Pacemaker Special Functions - An Educational Presentation. Braz J Cardiovasc Surg. 2021 Jun 1;36(3):412-415. doi: 10.21470/1678-9741-2020-0630.
PMID: 34387977BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markus Sane
Helsinki University Central Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D, PhD, Cardiologist
Study Record Dates
First Submitted
April 14, 2022
First Posted
April 25, 2022
Study Start
May 11, 2022
Primary Completion
June 1, 2022
Study Completion
August 20, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share